The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Vitamin D in chronic liver disease
Abstract
Chronic liver disease (CLD) and several related extrahepatic manifestations such as hepatic osteodystrophy are associated with deficiency of vitamin D, which has therefore been suggested as therapeutic target. Vitamin D undergoes hepatic 25‐hydroxylation, rendering the liver critical to the metabolic activation of this vitamin. Vitamin D deficiency is highly prevalent in CLD patients, and vitamin D levels are inversely related to the severity of CLD. Declining levels of carrier proteins such as albumin and vitamin D‐binding protein might also be critical in CLD. Intervention studies report improvements of CLD following supplementation, and benefits to health outcomes in particular with respect to hepatitis C virus infection have recently been documented. Content:We discuss vitamin D sources, functions and metabolism with a focus on the inherent complications of analytical measurements, such as the interference of 25‐hydroxyvitamin D and 1,25‐dihydroxyvitamin D C‐3 epimers. Global discrepancies in the definition of optimal serum 25‐hydroxyvitamin D levels are covered, and the prevalence of vitamin D deficiency in CLD is reviewed. We also address the functional mechanisms underlying this deficiency, and refer to associations between genetic variation in vitamin D metabolism and CLD. Lastly, we consider the health implications of a vitamin D deficiency in CLD and consider therapeutic options. Summary: Herein, we focus on the epidemiological and functional relationships between vitamin D deficiency and CLD, followed by a discussion of the potential implications for therapeutic interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Decreased bioavailability of vitamin D in obesity
Wortsman, J., Matsuoka, L. Y., Chen, T. C., Lu, Z., & Holick, M. F. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/72.3.690 · Cited by 3,204 · cited 1×
“In fact, obesity has been associated with low vitamin D levels due its sequestration, and hence reduced bioavailability (27).”
BackgroundHolick, M. F. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.6.1678s · Cited by 3,198
EASL Clinical Practice Guidelines: management of cholestatic liver diseases
European Association for the Study of the Liver (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.04.009 · Cited by 1,729
Guidelines on the management of osteoporosis associated with chronic liver disease
Collier, J. D., Ninkovic, M., & Compston, J. E. (2002) · Gut · doi:10.1136/gut.50.suppl_1.i1 · Cited by 241 · cited 12×
“Clin Liver Dis 2005; 9(4): 747-66, viii.”
BackgroundInfluentialBone disorders in chronic liver disease
Collier, J. (2007) · Hepatology · doi:10.1002/hep.21852 · Cited by 238
Bone disease in primary biliary cirrhosis: independent indicators and rate of progression
Menon, K. V. N., Angulo, P., Weston, S., Dickson, E. R., & Lindor, K. D. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00144-1 · Cited by 180 · cited 1×
“Conversely, others have failed to find evidence to support such correlations (73).”
BackgroundMiroliaee, A., Nasiri-Toosi, M., Khalilzadeh, O., Esteghamati, A., Abdollahi, A., & Mazloumi, M. (2010) · Hepatology International · doi:10.1007/s12072-010-9194-2 · Cited by 82 · cited 2×
“(41) Iran CLD group 56% Male Mean age 42.”
BackgroundRuiz-Gaspà, S., Martinez-Ferrer, A., Guañabens, N., Dubreuil, M., Peris, P., Enjuanes, A., de Osaba, M. J. M., Alvarez, L., Monegal, A., Combalia, A., et al. (2010) · Hepatology · doi:10.1002/hep.24605 · Cited by 75
Management of osteoporosis in liver disease
Guañabens, N., & Parés, A. (2011) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2011.03.007 · Cited by 56
Cited by
EASL Clinical Practice Guidelines on nutrition in chronic liver disease
Merli, M., Berzigotti, A., Zelber-Sagi, S., Dasarathy, S., Montagnese, S., Genton, L., Plauth, M., & Parés, A. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.06.024 · Cited by 1,130
The role of vitamin D and vitamin D binding protein in chronic liver diseases
Pop, T. L., Sîrbe, C., Benţa, G., Mititelu, A., & Grama, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810705 · Cited by 105
“In a recent study analyzing the VDBP level in children with ALF of various etiologies, we found that the level of VDBP in AIH was within the reference limits [25,28].”
BackgroundInfluentialVitamin D modulates biliary fibrosis in ABCB4-deficient mice
Hochrath, K., Stokes, C. S., Geisel, J., Pollheimer, M. J., Fickert, P., Dooley, S., & Lammert, F. (2014) · Hepatology International · doi:10.1007/s12072-014-9548-2 · Cited by 36
Self-citationHepatitis C virus infection and risk of osteoporosis: a meta-analysis
Wijarnpreecha, K., Thongprayoon, C., Panjawatanan, P., Phatharacharukul, P., & Ungprasert, P. (2017) · Saudi Journal of Gastroenterology · doi:10.4103/sjg.sjg_452_16 · Cited by 29
“[13,22] Furthermore, patients with chronic liver disease tend to have impaired hepatic hydroxylation of cholecalciferol, the first step in the synthesis of the active form of vitamin D, which could result in vitamin D deficiency and, ultimately, osteopenia/osteoporosis.[23,24]”
BackgroundBone health and vitamin D status in alcoholic liver disease
Kizilgul, M., Ozcelik, O., & Delibasi, T. (2016) · Indian Journal of Gastroenterology · doi:10.1007/s12664-016-0652-1 · Cited by 20
Metadata
- Authors
- Stokes, C. S., Volmer, D. A., Grünhage, F., & Lammert, F.
- Venue
- Liver International
- Publisher
- Wiley
- Published
- 2013-02-12
- Volume
- 33
- Issue
- 3
- Pages
- 338-352
- ISSN
- 0106-9543 (ISSN-L)
- 1478-3223
- 1478-3231
- OpenAlex
- W1994692075
- Cited by
- 194
- References
- 9
- FWCI
- 6.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Vitamin D in chronic liver disease. https://app.cochat.ai/papers/10.1111/liv.12106
- The paper
- Stokes, C. S., Volmer, D. A., Grünhage, F., & Lammert, F. (2013). Vitamin D in chronic liver disease. Liver International. https://doi.org/10.1111/liv.12106
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.